Treatment outcomes of patients switching from an injectable drug to bedaquiline during short standardized MDR-TB treatment in Mozambique.

Auteurs: Bastard M Molfino L Mutaquiha C Galindo MA Zindoga P Vaz D Mahinça I du Cros P Rusch B Telnov A
Référence de l'article: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Mar 11; (); Array. doi: 10.1093/cid/ciz196. Epub 2019 03 11
eng

Abstract

Bedaquiline was recommended by WHO as the preferred option in treatment of MDR-TB patients with long regimen. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched injectable dug to bedaquiline suggest that bedaquiline based short regimen is effective and safe.

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.